Monday, November 16, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Business & M&AInMode Q3 revenue holds near $92.1M, margins slip3 days agoRegulatoryJudge bars Medicare price for Botox over plasma rulelast weekRegulatoryMexico approves Restylane Shaype for jawline first3 days agoBusiness & M&AEvolus posts Q3 loss of $0.09, revenue tops estimateslast weekBusiness & M&ACoty shareholders approve 50M-share equity plan boost4 days agoMarketAllergan posts nine ASDS abstracts, two on GLP-1 patientslast weekDevices & TechConexeu's first human collagen batch meets its own specs5 days agoBusiness & M&AGalderma lifts 2026 sales outlook to 22.5-23.5%last weekBusiness & M&AMedytox Q3 operating profit up 74.5% on toxin sales5 days agoBusiness & M&ACytrellis Brings ellacor into UM Nurse Practitioner Courselast weekRegulatoryTrifluent recalls Tridacaine III lidocaine patch6 days agoRegulatoryFDA clears Shenzhen Bway red/NIR LED face mask6 days ago
Business & M&A

InMode Q3 revenue holds near $92.1M, margins slip

InMode reported flat third-quarter 2026 revenue, a 3% drop in consumables and service, and a GAAP operating margin down to 19% from 22%.

Concentrated colleagues sitting at table in modern workplace and discussing details of project during meeting in daytime
Photo: Anna Shvets / Pexels
1-YEAR MOVE
+3% −14%
INMD ▲1.0%
1-year price move by ticker
TickerCompany1-year change
INMDInMode Ltd.+1.0%

Get the free Inside MedSpa brief by email

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

InMode Ltd posted third-quarter 2026 GAAP revenue of $92.1 million, close to the $93.2 million it booked a year earlier, according to the company's announcement as reported by Medical Buyer. The top line held. The profit line did not.

What changed

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

Total GAAP revenues for the third quarter of 2026 were $92.1 million, broadly in line with the $93.2 million reported in the prior-year period.

Revenue was flat. Consumables and service fell 3% year over year to $19.3 million. InMode said Asia set another quarterly record, and that growth carried the quarter. The release does not break out Asia revenue in dollars, so the size of that gain is unknown.

Margins moved the other way. GAAP gross margin was 78%, unchanged from a year ago. Non-GAAP gross margin was also 78%. But the company said a non-recurring US tariff refund added about one percentage point to gross margin in the quarter. Strip that out and the underlying gross margin was closer to 77%.

Operating margin fell. GAAP operating margin was 19%, against 22% in Q3 2025. Non-GAAP operating margin was 22%, down from 25%. InMode blamed three things: the restructuring of its North American sales team at the end of 2025, higher sales and marketing spend to keep talent and market share, and more professional services cost in G&A. It also said those pressures will keep showing up in expenses for the foreseeable future.

Net income tells the same story. GAAP net income was $18.9 million, or $0.32 per diluted share, versus $21.9 million, or $0.34, a year ago. Non-GAAP net income was $21.9 million, or $0.37 per share, against $24.5 million, or $0.38. Cash, marketable securities and short-term bank deposits stood at $512.7 million on September 30, 2026.

Analysis

Our read: InMode is buying stability with margin. A flat top line with a shrinking operating margin means the company is spending more to hold position in North America, and the release gives no sign that spend is a one-time catch-up. The CFO's line that the results are "consistent with the stabilization we expect" is a fair description of the revenue. It says less about the cost base.

For an owner, the signal is the consumables number. Consumables and service are the recurring revenue that comes from treatments on installed systems. A 3% decline there, while capital equipment held steady quarter over quarter, suggests the installed base is not generating as much billed usage as it did last year. The release does not say why. We would not read a single quarter as a trend, but we would watch it.

What owners can do

Owners who buy or lease InMode platforms should ask their reps two things. First, how service and consumable pricing has changed since the North American sales restructuring, and whether any contract terms moved with it. Second, whether the sales coverage in your territory is the same team you dealt with a year ago. The company is telling investors that it is spending more to keep reps and accounts. That spending has to land somewhere, and buyers are the ones who see it.

Owners who sell competing devices should note that InMode is still putting money into talent and share defense. A price-sensitive market with a company willing to spend on sales is not a market that is getting easier.

What we don't know yet

The release does not give a North American revenue figure, so we cannot tell whether the US region is flat, down, or offset by growth elsewhere. It does not name the amount of the tariff refund. It does not say how long the professional services costs will last. And it reaffirmed full-year 2026 guidance of $365 million to $375 million in revenue, with non-GAAP operating income of $68 million to $73 million and non-GAAP diluted EPS of $1.29 to $1.34, without saying what the fourth quarter has to deliver to hit those ranges. The fourth quarter is the test.

Business information, not medical or legal advice. Verify regulatory status at FDA.gov.

Source: original report ↗

Business information, not medical or legal advice. Verify product status at FDA.gov.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

Share

https://insidemedspa.com/article/inmode-q3-2026-revenue-92-1m-margins-slip/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa · Free brief

    By the time it's news, it's too late.

    FDA decisions, recalls and the rules you operate under, drafted from the source documents and sent free by email.

    Get the free brief The free Inside MedSpa brief · no card · unsubscribe anytime.
    FDA, recalls and rule changes for practice owners Get the free brief →